CRISPR Therapeutics grants CFO Andrew Jacob Silver 25,000 restricted stock units
CRSP•CRISPR Therapeutics granted CFO Andrew Jacob Silver 25,000 restricted stock units on October 19, 2026.
1. Restricted stock grant
CRISPR Therapeutics granted Chief Financial Officer Andrew Jacob Silver 25,000 restricted stock units on October 19, 2026.
